Quick Answer
REPLIGEN CORP reported Total Revenue of $141.24 million for fiscal year 2017.
REPLIGEN CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | $48.89M +291.6% |
-$25.51M -171.7% |
$35.60M -80.9% |
$185.96M +45.0% |
$128.29M +114.1% |
$59.93M +179.9% |
| Diluted EPS | $0.86 +287.0% |
-$0.46 -173.0% |
$0.63 -80.6% |
$3.24 +44.6% |
$2.24 +101.8% |
$1.11 +152.3% |
| Total Assets | $2.95B +4.2% |
$2.83B -0.1% |
$2.83B +12.1% |
$2.52B +7.1% |
$2.36B +23.9% |
$1.90B +35.9% |
| Cash and Equivalents | $566.02M -25.3% |
$757.36M +0.8% |
$751.32M +43.5% |
$523.46M -13.3% |
$603.81M -15.8% |
$717.29M +35.7% |
| Long-Term Debt | $542.21M +3.2% |
$525.57M | — | — | — | — |
| Stockholders Equity | $2.11B +6.8% |
$1.97B +0.4% |
$1.96B +2.8% |
$1.91B +9.2% |
$1.75B +14.4% |
$1.53B +44.3% |
| R&D Expense | $54.18M +25.4% |
$43.20M +1.1% |
$42.72M -2.8% |
$43.94M +28.2% |
$34.27M +69.8% |
$20.18M +3.8% |
| Operating Income | $55.17M +257.1% |
-$35.11M -173.6% |
$47.70M -78.8% |
$224.67M +34.3% |
$167.25M +139.5% |
$69.82M +93.5% |
| Shares Outstanding | 56.33M +0.4% |
56.09M +0.6% |
55.77M +0.4% |
55.56M +0.4% |
55.32M +1.0% |
54.76M +5.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2018 | $44.83M | +46.6% | +22.6% |
| Net Income | September 30, 2025 | $14.91M | +2380.0% | +0.3% |
| Diluted EPS | September 30, 2025 | $0.26 | +2700.0% | +0.0% |
| Total Assets | September 30, 2025 | $2.92B | +3.3% | +0.8% |
| Cash and Equivalents | September 30, 2025 | $748.75M | -4.5% | +5.6% |
| Long-Term Debt | September 30, 2025 | $537.93M | — | +2.4% |
| Stockholders Equity | September 30, 2025 | $2.08B | +3.3% | +1.0% |
| R&D Expense | September 30, 2025 | $14.18M | +46.0% | +1.6% |
| Operating Income | September 30, 2025 | $16.82M | +314.8% | +21.1% |
| Shares Outstanding | September 30, 2025 | 56.28M | +0.5% | +0.1% |
- REPLIGEN CORP reported Total Revenue of $141.24 million for fiscal year 2017.
- REPLIGEN CORP showed an increase of +35.1% in Total Revenue compared to the prior fiscal year.
- REPLIGEN CORP reported Net Income of $48.89 million for fiscal year 2025.
- REPLIGEN CORP showed an increase of +291.6% in Net Income compared to the prior fiscal year.
- REPLIGEN CORP reported Diluted EPS of $0.86 per share for fiscal year 2025.
- REPLIGEN CORP showed an increase of +287.0% in Diluted EPS compared to the prior fiscal year.
- REPLIGEN CORP reported Total Assets of $2.95 billion for fiscal year 2025.
- REPLIGEN CORP showed an increase of +4.2% in Total Assets compared to the prior fiscal year.
- REPLIGEN CORP reported Cash and Equivalents of $566.02 million for fiscal year 2025.
- REPLIGEN CORP showed a decrease of -25.3% in Cash and Equivalents compared to the prior fiscal year.
- REPLIGEN CORP reported Long-Term Debt of $542.21 million for fiscal year 2025.
- REPLIGEN CORP showed an increase of +3.2% in Long-Term Debt compared to the prior fiscal year.
- REPLIGEN CORP reported Stockholders Equity of $2.11 billion for fiscal year 2025.
- REPLIGEN CORP showed an increase of +6.8% in Stockholders Equity compared to the prior fiscal year.
- REPLIGEN CORP reported R&D Expense of $54.18 million for fiscal year 2025.
- REPLIGEN CORP showed an increase of +25.4% in R&D Expense compared to the prior fiscal year.
- REPLIGEN CORP reported Operating Income of $55.17 million for fiscal year 2025.
- REPLIGEN CORP showed an increase of +257.1% in Operating Income compared to the prior fiscal year.
- REPLIGEN CORP reported Shares Outstanding of 56.33 million shares for fiscal year 2025.
- REPLIGEN CORP showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: